Invention Application
- Patent Title: BIOENGINEERED T CELL MEDIATED IMMUNITY, MATERIALS AND OTHER METHODS FOR MODULATING CLUSTER OF DIFFERENTIATION IV &/OR VIII
-
Application No.: US17499597Application Date: 2021-10-12
-
Publication No.: US20220112288A1Publication Date: 2022-04-14
- Inventor: Rajkumar GANESAN , Sanjaya SINGH , Iqbal S. GREWAL , Michael Riis HANSEN
- Applicant: JANSSEN BIOTECH, INC.
- Applicant Address: US PA Horsham
- Assignee: JANSSEN BIOTECH, INC.
- Current Assignee: JANSSEN BIOTECH, INC.
- Current Assignee Address: US PA Horsham
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/46
Abstract:
Provided herein, in certain aspects, are antibodies that bind to CD8, as well as recombinant cells containing the vectors, and compositions comprising the antibodies. Also provided herein, in certain aspects, are antibodies that bind to CD4, as well as recombinant cells containing the vectors, and compositions comprising the antibodies. Also provided herein, in certain aspects, are multispecific antibodies that bind to CD4 and CD8, as well as recombinant cells containing the vectors, and compositions comprising the antibodies. Methods of making the antibodies are also provided.
Public/Granted literature
Information query
